Loading insider details...
Latest Form 4 (Mar 4, 2026): Grant/Award of 50,000 CATX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 4, 2026 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 50,000 | n/a |
| Nov 14, 2025 | Perspective Therapeutics, Inc. (CATX) | Purchase | 9,498 | $19.9K |
| Apr 1, 2025 | Perspective Therapeutics, Inc. (CATX) | Purchase | 22,192 | $50.4K |
| Mar 5, 2025 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 50,000 | n/a |
| Nov 27, 2024 | Perspective Therapeutics, Inc. (CATX) | Purchase | 3,647 | $13.2K |
| Jun 24, 2024 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 23,000 | n/a |
| Jun 3, 2024 | Perspective Therapeutics, Inc. (CATX) | Purchase | 55,000 | $75.9K |
| May 30, 2024 | Perspective Therapeutics, Inc. (CATX) | Purchase | 11,375 | $15.0K |
| Feb 1, 2024 | Perspective Therapeutics, Inc. (CATX) | Purchase | 18,579 | $13.2K |
| Jan 30, 2024 | Perspective Therapeutics, Inc. (CATX) | Purchase | 12,250 | $7.5K |